Ktenders

Other · East of England

Supply, Delivery, Installation, Commissioning and Post-Warranty Maintenance of Digital PCR (dPCR) System for Haemoto-oncology Assays

CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST · Closes 13:00 on 16 December 2026 · 26 days left

What this tender is

CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST is seeking suppliers for “Supply, Delivery, Installation, Commissioning and Post-Warranty Maintenance of Digital PCR (dPCR) System for Haemoto-oncology Assays”. It is classed as other goods, with delivery in East of England.

In the buyer's own words: The Cambridge Genomics Lab provides a comprehensive range of genomic testing for patients with haematological malignancies (haem-onc), with solid cancer, and with rare disease. In the haem-onc setting, we currently utilise a range of molecular techniques including Next-generation sequencing, quantitative PCR, and fragment analysis to identify and monitor clinically significant genomic alterations. However, there is an increasing requirement for high sensitivity, quantitative molecular testing both to support diagnosis and for disease monitoring / assessment of therapeutic response. We are…

The tender is being run under an open procedure, so any supplier may bid.

The estimated value is £270k, as stated by the buyer; the final value can differ.

Ktenders places each notice in a trade from the classification code the buyer chose and in a region from the delivery location it gives, so if the scope looks different from the trade shown here, the official notice is the one to trust.

Who it suits

This tender is most relevant to other suppliers able to deliver in East of England.

At this size buyers usually expect evidence of similar work, appropriate insurance and stable finances, so smaller firms often bid as part of a consortium or as a subcontractor.

Public buyers in the UK must treat suppliers equally and explain how bids will be scored, so the selection and award criteria in the tender documents are the best guide to whether this opportunity is worth your time.

Before deciding to bid, read the full notice and any attached documents: they set out the exact requirements, selection criteria and how bids will be scored.

Key dates

The notice was published on 16 November 2026.

Responses are due by 13:00 UK time on 16 December 2026, which is 26 days from today.

Most buyers set a cut-off for clarification questions a few days before the deadline, and the answers are usually shared with every bidder on the buyer's portal.

Deadlines on public tenders are strict: late submissions are normally rejected, so allow time for clarification questions and for uploading your response on the buyer's portal.

Original notice text

The Cambridge Genomics Lab provides a comprehensive range of genomic testing for patients with haematological malignancies (haem-onc), with solid cancer, and with rare disease. In the haem-onc setting, we currently utilise a range of molecular techniques including Next-generation sequencing, quantitative PCR, and fragment analysis to identify and monitor clinically significant genomic alterations. However, there is an increasing requirement for high sensitivity, quantitative molecular testing both to support diagnosis and for disease monitoring / assessment of therapeutic response.

We are therefore looking to procure a Digital / Digital Droplet (dPCR / ddPCR) system to complement the laboratory’s existing molecular testing capabilities. This would also intend to facilitate the consolidation of multiple existing assays and methodologies onto a single technology platform.

More other tenders

All other tenders →

More tenders in East of England

All tenders in East of England →

Closing soon

All live tenders by trade →